$0.12
(Market cap
$497 Mln
Recently Viewed
Clear AllMarket cap
$497 Mln
Revenue (TTM)
$822 Mln
P/E Ratio
--
P/B Ratio
1.1
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
-0.2 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
59.7
Debt to Equity
0.5
Book Value
$11.3
EPS
$-2.3
Face value
--
Shares outstanding
40,144,397
CFO
$309.64 Mln
EBITDA
$189.47 Mln
Net Profit
$-223.72 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Orthofix Medical Inc. (DE) (OFIX)
| -15.8 | 9.1 | -13.8 | -6.6 | -10.8 | -21.7 | -11.1 |
|
BSE Sensex*
| -9.2 | 1.1 | -8.4 | 2.2 | 8.4 | 9.9 | 11.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Orthofix Medical Inc. (DE) (OFIX)
| -13.2 | 29.3 | -34.3 | -34.0 | -27.7 | -6.9 | -12.0 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Orthofix Medical Inc. (DE) (OFIX)
|
12.8 | 497.0 | 822.3 | -92.2 | -8.9 | -19.3 | -- | 1.1 |
| 8.2 | 5,388.2 | 6,552.2 | -530.2 | -4.1 | -9.2 | -- | 1.0 | |
| 277.0 | 7,476.3 | 2,583.2 | 759.9 | 25.2 | 10.8 | 9.9 | 1.0 | |
| 40.0 | 5,721.9 | 3,436.5 | -8.6 | 2.2 | -0.4 | -- | 2.3 | |
| 121.2 | 6,760.4 | 507.4 | -187.7 | -36.2 | -26.4 | -- | 10.3 | |
| 82.7 | 5,246.6 | 1,541.6 | 233.6 | 21.6 | 21.4 | 23.6 | 4.8 | |
| 178.5 | 9,337.3 | 1,526.9 | -151.5 | 20.0 | -17.1 | 46.6 | 12.9 | |
| 332.1 | 12,941.2 | 1,403.7 | 177.7 | 14.7 | 13.8 | 73 | 9.1 | |
| 130.8 | 6,773.6 | 738.3 | 48.9 | 11.4 | 2.4 | 139.7 | 3.2 | |
| 34.4 | 14,139.4 | 6,178.4 | 626.5 | 13.0 | 11.9 | 23.2 | 2.6 |
Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global... Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and 7D FLASH Navigation System, a navigation platform for spinal and cranial procedures. The Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market, including deformity correction, limb lengthening, complex fracture management, and limb preservation. This segment also designs, develops, and markets external and internal fixation limb reconstruction products that are coupled with enabling digital technologies to support the entire patient care continuum. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, healthcare providers, ambulatory surgery centers, and out-patient hospitals. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas. Address: 3451 Plano Parkway, Lewisville, TX, United States, 75056 Read more
President of Global Orthopedics
Ms. Kimberley A. Elting
President of Global Orthopedics
Ms. Kimberley A. Elting
Headquarters
Lewisville, TX
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Orthofix Medical Inc (DE) (OFIX) is $12.77 (NASDAQ) as of 14-Apr-2026 15:32 EDT. Orthofix Medical Inc (DE) (OFIX) has given a return of -10.81% in the last 3 years.
Since, TTM earnings of Orthofix Medical Inc (DE) (OFIX) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-6.58
|
1.35
|
|
2024
|
-5.36
|
1.34
|
|
2023
|
-3.32
|
0.84
|
|
2022
|
-21.00
|
1.23
|
|
2021
|
-16.09
|
1.83
|
The 52-week high and low of Orthofix Medical Inc (DE) (OFIX) are Rs 16.99 and Rs 10.24 as of 15-Apr-2026.
Orthofix Medical Inc (DE) (OFIX) has a market capitalisation of $ 497 Mln as on 13-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Orthofix Medical Inc (DE) (OFIX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.